Home LiteratureArticle Details
PMID: 41129288 Published · ppublish English

Postpartum Intrauterine Device Removal and Access to Removal in the 18 Months Following an Intervention in Tanzania, Sri Lanka, and Nepal.

Studies in family planning ·Vol. 57 ·No. 1 ·2026-03-00

Bullington BW, Tumlinson K, Senderowicz L, Maselko J, Arora KS, Edwards JK, Pettifor A

Abstract

Family planning programs in the Global South promote long-acting reversible contraception (LARC), but research suggests that women face barriers to LARC discontinuation, inhibiting their reproductive autonomy. Scholars have called for improved data visibility around LARC removal access. We use data from the Postpartum Intrauterine Device (PPIUD) Study, a randomized trial of a PPIUD intervention conducted in Nepal, Sri Lanka, and Tanzania from 2015 to 2018. Among women who adopted PPIUDs, we describe PPIUD status (in-use, expelled, deliberately removed) at three follow-up points. We report the proportion of participants who sought PPIUD removal and, among those, whether they faced barriers to removal. About three-quarters of 5370 participants had their PPIUD in use 18 months following insertion; one-fifth had their PPIUD deliberately removed, and 6 percent had their PPIUD expelled. Of the 22 percent of participants who sought PPIUD removal, a quarter faced a barrier to removal; most barriers were provider-imposed. In conjunction with existing literature, our findings highlight that barriers to LARC removal are structural, rooted in larger public health and demographic goals that aim to promote contraceptive uptake. We call for safeguards to ensure that people who desire LARC removal can discontinue their method.

Article Info
Journal
Studies in family planning
Abbr.
Stud Fam Plann
ISSN
1728-4465
Published
2026-03-00
Language
English
Country/Region
United States
NLM ID
7810364
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]